Pression
1 known investors
Find your way into Pression
Sign up to see every warm intro you have to Pression
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pression team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pression develops a non-invasive external counterpulsation (ECP) heart therapy delivered through lightweight calf sleeves for adults with Chronic Stable Angina who are not candidates for revascularization. Its device targets clinics and hospitals, aiming to make clinically validated ECP therapy easier to deliver with less setup time and minimal staff involvement.
Investors · 1
Frequently asked questions
- What does Pression do?
- Pression develops a non-invasive external counterpulsation (ECP) heart therapy delivered through lightweight calf sleeves for adults with Chronic Stable Angina who are not candidates for revascularization. Its device targets clinics and hospitals, aiming to make clinically validated ECP therapy easier to deliver with less setup time and minimal staff involvement.
- Who are Pression's investors?
- Pression's investors include Garden State Venture Partners.
